Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumors

Competing Interest Statement

AJW is on the Scientific Advisory Boards for Alexion and DayOne. AJW has served as a consultant for Ipsen. MB is a consultant for Alexion and Springworks.

Funding Statement

This work was funded in part by National Institutes of Health (NIH) grants R03CA287169 (SJD, JLR), R03OD036498 (JLR), U24OD038422 (SJD, JLR), the NIH Kids First Cloud Credits Program (SJD, JLR), the Children's Brain Tumor Network, and the Chad Tough Foundation.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Datasets were obtained using dbGAP access request, CBTN data access request, and PNOC data access request. Ethics committees of the CBTN, PNOC, and NIH have approved this work. Sample and patient IDs included in this manuscript are de-identified and are public/open-access identifiers already published in the Gabriella Miller Kids First portal.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes